相关实验视频
Updated: Jun 12, 2025

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
探索海洋的癌症治疗方法:海洋衍生生物活性的承诺
Diana Rafieezadeh1, Mohammadjavad Abbaspour2
1Department of Cellular and Molecular Biology, Razi University Kermanshah, Iran.
International journal of biochemistry and molecular biology
|September 23, 2024
概括
海洋生物提供有前途的抗癌,其中一些如Stylisin和Papuamides已经进入临床试验. 研究强调了它们在新型癌症治疗中的潜力,因为它们通过向关键细胞过程来治疗癌症.
科学领域:
- 海洋生物技术 海洋生物技术
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 海洋生态系统是生物活性化合物的丰富来源.
- 像海绵,衣动物和软体动物这样的海洋生物的体显示出显著的抗癌潜力.
- 其中的例子包括斯蒂利辛,帕普阿米德,贾斯帕米德,荷莫菲明,阿普利丁和卡哈拉利德F.
研究的目的:
- 审查海洋衍生的抗癌性质.
- 探索它们的治疗潜力和作用机制.
- 突出海洋天然产品在癌症药物发现中的重要性.
主要方法:
- 从海洋来源分离和识别生物活性.
- 化学修饰以增强的活性.
- 酶性水解用于提取,特别是从海绵中提取.
- 对抗癌细胞系的细胞毒性活动的评估.
- 研究包括诱导亡,微管子动态和血管生成抑制在内的机制.
主要成果:
- 几种海洋,包括斯蒂利辛和帕普阿米德,已经显示出强大的抗癌活性,并进展到临床试验.
- 海洋海绵被确定为特别丰富的细胞毒性化合物的来源,如贾斯帕米德和荷莫菲明.
- 来自类动物和软体动物的,如阿普利丁和卡哈拉利德F,也表现出显著的抗癌特性.
- 这些可以向关键的癌症途径,提供多种不同的治疗策略.
结论:
- 海洋衍生代表了开发新型抗癌疗法的有希望的资源.
- 进一步的研究是必要的,以充分实现这些天然化合物的治疗益处.
- 海洋天然产品为创新的癌症治疗策略提供了宝贵的途径.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K

